Chunbo Valuation

Is A278280 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A278280 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A278280 (₩41350) is trading above our estimate of fair value (₩3544.39)

Significantly Below Fair Value: A278280 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for A278280?

Key metric: As A278280 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A278280. This is calculated by dividing A278280's market cap by their current revenue.
What is A278280's PS Ratio?
PS Ratio2.5x
Sales₩164.09b
Market Cap₩420.54b

Price to Sales Ratio vs Peers

How does A278280's PS Ratio compare to its peers?

The above table shows the PS ratio for A278280 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.1x
A004430 Songwon Industrial
0.2xn/a₩258.7b
A011500 Hannong Chemicals
0.9xn/a₩224.8b
A033500 Dongsung FineTec
0.7x12.1%₩369.9b
A126560 Hyundai Futurenet
2.4xn/a₩402.1b
A278280 Chunbo
2.5x32.1%₩420.5b

Price-To-Sales vs Peers: A278280 is expensive based on its Price-To-Sales Ratio (2.5x) compared to the peer average (1.1x).


Price to Sales Ratio vs Industry

How does A278280's PS Ratio compare vs other companies in the KR Chemicals Industry?

8 CompaniesPrice / SalesEstimated GrowthMarket Cap
A011170 Lotte Chemical
0.1x4.3%US$2.03b
A000210 DL Holdings
0.1x1.8%US$546.21m
A012630 HDC HOLDINGSLtd
0.09xn/aUS$404.48m
A005950 ISU Chemical
0.08xn/aUS$107.48m
A278280 2.5xIndustry Avg. 0.6xNo. of Companies28PS00.61.21.82.43+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: A278280 is expensive based on its Price-To-Sales Ratio (2.5x) compared to the KR Chemicals industry average (0.6x).


Price to Sales Ratio vs Fair Ratio

What is A278280's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A278280 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.5x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: A278280 is expensive based on its Price-To-Sales Ratio (2.5x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A278280 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩41,350.00
₩69,666.67
+68.5%
41.1%₩131,000.00₩40,000.00n/a9
Nov ’25₩54,300.00
₩78,222.22
+44.1%
30.9%₩131,000.00₩42,000.00n/a9
Oct ’25₩60,400.00
₩80,777.78
+33.7%
28.9%₩131,000.00₩42,000.00n/a9
Sep ’25₩59,800.00
₩83,000.00
+38.8%
29.0%₩131,000.00₩42,000.00n/a9
Aug ’25₩62,700.00
₩88,777.78
+41.6%
25.5%₩131,000.00₩42,000.00n/a9
Jul ’25₩73,600.00
₩98,800.00
+34.2%
23.2%₩150,000.00₩76,000.00n/a10
Jun ’25₩73,500.00
₩116,166.67
+58.0%
40.8%₩250,000.00₩76,000.00n/a12
May ’25₩77,700.00
₩133,833.33
+72.2%
32.5%₩250,000.00₩81,000.00n/a12
Apr ’25₩88,200.00
₩143,538.46
+62.7%
37.4%₩260,000.00₩81,000.00n/a13
Mar ’25₩90,300.00
₩143,538.46
+59.0%
37.4%₩260,000.00₩81,000.00n/a13
Feb ’25₩83,800.00
₩157,076.92
+87.4%
35.2%₩260,000.00₩81,000.00n/a13
Jan ’25₩110,200.00
₩160,153.85
+45.3%
33.9%₩260,000.00₩81,000.00n/a13
Dec ’24₩104,900.00
₩160,153.85
+52.7%
33.9%₩260,000.00₩81,000.00n/a13
Nov ’24₩97,100.00
₩217,333.33
+123.8%
32.1%₩343,000.00₩110,000.00₩54,300.0012
Oct ’24₩130,900.00
₩258,583.33
+97.5%
17.3%₩343,000.00₩160,000.00₩60,400.0012
Sep ’24₩148,700.00
₩266,083.33
+78.9%
18.8%₩343,000.00₩160,000.00₩59,800.0012
Aug ’24₩189,600.00
₩297,545.45
+56.9%
15.1%₩350,000.00₩230,000.00₩62,700.0011
Jul ’24₩192,600.00
₩297,545.45
+54.5%
15.1%₩350,000.00₩230,000.00₩73,600.0011
Jun ’24₩188,100.00
₩300,272.73
+59.6%
15.7%₩350,000.00₩230,000.00₩73,500.0011
May ’24₩193,700.00
₩304,818.18
+57.4%
13.9%₩350,000.00₩240,000.00₩77,700.0011
Apr ’24₩250,000.00
₩315,300.00
+26.1%
8.7%₩350,000.00₩270,000.00₩88,200.0010
Mar ’24₩252,000.00
₩321,090.91
+27.4%
11.5%₩400,000.00₩270,000.00₩90,300.0011
Feb ’24₩243,500.00
₩321,090.91
+31.9%
11.5%₩400,000.00₩270,000.00₩83,800.0011
Jan ’24₩218,300.00
₩326,545.45
+49.6%
13.6%₩410,000.00₩270,000.00₩110,200.0011
Dec ’23₩247,200.00
₩326,545.45
+32.1%
13.6%₩410,000.00₩270,000.00₩104,900.0011
Nov ’23₩218,600.00
₩342,000.00
+56.5%
14.4%₩410,000.00₩270,000.00₩97,100.0010

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies